Earnings calendar/KYMR
Kymera Therapeutics, Inc. (KYMR)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-1.25
Street estimate
Revenue target
$3.8M
Street estimate
Trailing EPS (avg 4Q)
$-0.80
Beat rate last 4: 50%
Latest EPS YoY
+34.7%
vs 2025-08-11
Latest revenue YoY
+466.4%
How results look so far
Trailing revenue (avg 4Q)
$26.3M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS beat
EPS actual / est
$-0.62 / $-0.71
+13.0%
Revenue actual / est
$65.0M / $32.8M
+98.3%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-1.25 | Pending | — | $3.8M | Pending | — |
| 8/5/2026 | $-0.71 | $-0.62 | +13.0% | $32.8M | $65.0M | +98.3% |
| 5/8/2026upcoming | $-0.89 | Pending | — | $8.3M | Pending | — |
| 4/30/2026 | $-0.89 | $-0.71 | +20.2% | $8.3M | $34.4M | +315.7% |
| 2/26/2026 | $-0.78 | $-0.97 | -23.8% | $15.0M | $2.9M | -80.9% |
| 11/4/2025 | $-0.71 | $-0.90 | -26.8% | $14.5M | $2.8M | -80.9% |
| 8/11/2025 | $-0.83 | $-0.95 | -14.5% | $17.1M | $11.5M | -33.0% |
| 5/9/2025 | $-0.92 | $-0.82 | +10.9% | $12.4M | $22.1M | +78.5% |
| 2/27/2025 | $-0.76 | $-0.88 | -15.8% | $16.7M | $7.4M | -55.7% |
| 10/31/2024 | $-0.83 | $-0.82 | +1.2% | $15.2M | $3.7M | -75.4% |
| 8/7/2024 | $-0.69 | $-0.58 | +15.9% | $12.6M | $25.6M | +104.4% |
| 5/2/2024 | $-0.73 | $-0.69 | +5.5% | $13.7M | $10.3M | -24.9% |
| 2/22/2024 | $-0.44 | $-0.25 | +43.2% | $42.0M | $47.9M | +14.1% |
| 11/2/2023 | $-0.73 | $-0.90 | -23.3% | $16.0M | $4.7M | -70.4% |
| 8/3/2023 | $-0.70 | $-0.67 | +4.3% | $14.1M | $16.5M | +17.4% |
| 5/4/2023 | $-0.69 | $-0.70 | -1.4% | $14.2M | $9.5M | -33.1% |
| 2/23/2023 | $-0.57 | $-0.60 | -5.3% | $22.1M | $16.1M | -26.8% |
| 11/3/2022 | $-0.70 | $-0.79 | -12.9% | $15.5M | $9.6M | -38.4% |
| 8/9/2022 | $-0.68 | $-0.78 | -14.7% | $14.2M | $11.5M | -19.1% |
| 5/3/2022 | $-0.67 | $-0.71 | -6.0% | $18.7M | $9.6M | -48.7% |
| 2/24/2022 | $-0.36 | $-0.66 | -83.3% | $21.3M | $15.3M | -28.3% |
| 11/10/2021 | $-0.34 | $-0.56 | -64.7% | $17.8M | $20.3M | +14.5% |
| 8/6/2021 | $-0.21 | $-0.55 | -161.9% | $18.5M | $18.5M | 0.0% |
| 5/6/2021 | $-0.17 | $-0.29 | -70.6% | $15.6M | $18.7M | +19.7% |
| 3/11/2021 | $0.09 | $-0.29 | -422.2% | — | $12.8M | — |
| 11/5/2020 | $-0.21 | $-0.39 | -85.7% | $11.6M | $14.5M | +25.7% |
| 8/21/2020 | — | $-0.25 | — | — | $3.4M | — |
| 6/30/2020 | — | $-0.32 | — | — | $3.3M | — |
| 12/31/2019 | — | $-0.26 | — | — | $1.8M | — |
| 9/30/2019 | — | $-0.26 | — | — | $950,000 | — |